Chemical Compound

CLEMASTINE FUMARATE

CAS Registry Number 14976-57-9
CLEMASTINE FUMARATE chemical structure
Primary Record

CLEMASTINE FUMARATE

In stock
3,547 g
Purity
98.1 %
CAS
14976-57-9

Compound Identifiers & Properties

CAS
14976-57-9
PubChem CID
5281069
SMILES
C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C.C(=C/C(=O)O)\C(=O)O
Canonical SMILES
CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O

Names & Synonyms

  • CLEMASTINE FUMARATE
  • Agasten
  • Tavist
  • clemastine
  • Mecloprodine
  • Aloginan
  • Xolamin
  • Fuluminol
  • Kinotomin
  • Marsthine
  • Masletine
  • Alphamin
  • Anhistan
  • Clemanil
  • Inbestan
  • Lacretin
  • Lecasol
  • Piloral
  • Reconin
  • Tavegil
  • Trabest
  • 14976-57-9
  • Maikohis
  • Mallermin-F
  • Tavegyl
  • Telgin-G
  • Tavist-1
  • Clemastina
  • Clemastinum
  • Mecloprodin
  • Meclastin
  • Clemastine hydrogen fumarate
  • Mixture Name
  • Meclastine fumarate
  • Clemastine (fumarate)
  • Prestwick_680
  • Meclastine hydrogen fumarate
  • Topcare dayhist allergy
  • Clemastine Fumarate?
  • HS-592;Meclastine
  • Contac 12 Hour Allergy
  • AC1NQXZB
  • TAVIST D
  • TAVIST-D
  • Clemastine fumarate CRS
  • Clemastine fumarate salt
  • clemastine; fumaric acid
  • RefChem:56360
  • C25H30ClNO5
  • Clemastine [USAN:BAN]
  • Clemastinum [INN-Latin]
  • Clemastina [INN-Spanish]
  • DTXSID6047785
  • C21H26ClNO
  • HSDB 6507
  • UNII-19259EGQ3D
  • C21H26ClNO.C4H4O4
  • CHEBI:3739
  • 19259EGQ3D
  • UNII-95QN29S1ID
  • MFCD00137486
  • SCHEMBL33403
  • DTXCID6027765
  • Tavist Allergy/Sinus/Headache
  • Clemastine [USAN:INN:BAN]
  • SPECTRUM1500191
  • EINECS 239-055-2
  • PMGQWSIVQFOFOQ-YKVZVUFRSA-N
  • HY-B0298AR
  • Tavist;Xolamin;Agasten;Aloginan
  • C21-H26-Cl-N-O
  • CHEMBL1200795
  • Clemastine for system suitability
  • HMS500O07
  • HY-B0298A
  • CLEMASTINE FUMARATE [JAN]
  • Clemastine (fumarate) (Standard)
  • Clemastine fumarate [USAN:BAN:JAN]
  • CLEMASTINE FUMARATE [HSDB]
  • CLEMASTINE FUMARATE [USAN]
  • HMS1568N14
  • HMS1920O13
  • HMS2091E20
  • HMS2095N14
  • HMS3267L12
  • HMS3412B19
  • HMS3676B19
  • HMS3712N14
  • HMS3884K12
  • Pharmakon1600-01500191
  • CLEMASTINE FUMARATE [VANDF]
  • BCP27945
  • CLEMASTINE FUMARATE [MART.]
  • MSK10900
  • Tox21_110574
  • CCG-40028
  • CLEMASTINE FUMARATE [USP-RS]
  • CLEMASTINE FUMARATE [WHO-DD]
  • HS 592
  • NP3342
  • NSC756685
  • s1847
  • 14976-57-9 (FUMARATE)
  • Clemastine for system suitability CRS
  • (R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine fumarate
  • AKOS015896237
  • AKOS037643271
  • Clemastine fumarate [USAN:USP:BAN:JAN]
  • Tox21_110574_1
  • AC-1338
  • CID5281069
  • CS-2331
  • CS-O-06237
  • NSC-756685
  • Clemastine fumarate - Bio-X trade mark
  • CLEMASTINE FUMARATE [ORANGE BOOK]
  • CLEMASTINE HYDROGEN FUMARATE [MI]
  • NCGC00016710-01
  • NCGC00016710-05
  • NCGC00180903-01
  • NCGC00180903-02
  • AS-12093
  • BC164321
  • BC206422
  • C21-H26-Cl-N-O.C4-H4-O4
  • CLEMASTINE FUMARATE [EP MONOGRAPH]
  • CLEMASTINE FUMARATE [USP MONOGRAPH]
  • Clemastine fumarate salt, >=98% (HPLC)
  • HS-592 (fumarate);Meclastine (fumarate)
  • AB2000329
  • CAS-14976-57-9
  • LS-137507
  • B1558
  • FT-0656312
  • ST24046356
  • SW196835-3
  • TAVIST-D COMPONENT CLEMASTINE FUMARATE
  • A10226
  • H10994
  • K-4763
  • 976C579
  • A808955
  • F859378
  • SR-05000001590
  • (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine fumarate (1:1)
  • I06-2109
  • SR-05000001590-1
  • (+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl pyrrolidine fumarate
  • Q27106180
  • 14976-57-9, 15686-51-8 (base)
  • 15686-51-8
  • Pyrrolidine,2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-,(2E)-2-butenedioate (1:1)
  • (2E)-but-2-enedioic acid; (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine
  • Pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (R-(R*,R*))-, (E)-2-butenedioate (1:1)
  • 2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin
  • Clemastine fumarate, European Pharmacopoeia (EP) Reference Standard
  • (R-(R*,R*))-2-(2-(1-(p-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium hydrogen fumarate
  • Clemastine fumarate, United States Pharmacopeia (USP) Reference Standard
  • Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-, fumarate (1:1)
  • (+)-2-[2-[(p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine
  • (2R)-2-(2-((1R)-1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine monofumarate
  • (2R)-2-[2-[(1R)-1-(4-Chlor-ophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
  • (2R)-2-[2-[(1R)-1-(4-Chlorophenylethoxy]ethyl]-1-methyl-2-pyrrolidine fumarate
  • (R)-2-[2-[(R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate
  • Clemastine for system suitability, European Pharmacopoeia (EP) Reference Standard
  • Pirrolidina, 2-[2-[(1R)-1-(4-clorofenil)-1-fenilethoxi] etil]-1-metil-, (2R)-
  • Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-
  • Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-
  • (+)-(2R)-2-(2-(((R)-P-CHLORO-.ALPHA.-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYL)-1-METHYLPYRROLIDINE FUMARATE (1:1)
  • (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
  • (2E)-But-2-enedioic acid--(2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine (1/1)
  • (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]-1-methyl-pyrrolidine;fumaric acid
  • (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidin-1-ium;(E)-4-hydroxy-4-oxobut-2-enoate
  • (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine (2E)-but-2-enedioate
  • (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidinium (2E)-3-carboxyprop-2-enoate
  • (E)-but-2-enedioic acid; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
  • (E)-but-2-enedioic acid;(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
  • [R-(R*,R*)]-2-[2-[1-(p-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidinium hydrogen fumarate
  • Clemastine fumarate; (2R)-2-[2-[(R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine (E)-butenedioate; Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-, (2E)-2-butenedioate (1:1); Clemastine Fumarate; Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-, (E)-2-butenedioate (1:1); Agasten; Aloginan; Alphamin; Anhistan; Bravegyl; Clemastine hydrogen fumarate; Fuluminol; HS 592; Inbestan; Kinotomin; Lacretin; Lecasol; Maikohis; Mallermin F; Marsthine; Masletine; Meclastine fumarate; Mecloprodine; Piloral; Reconin; Tavegil; Tavegyl; Tavist; Telgin; Telgin G; Trabest; Xolamin; Pyrrolidine, 2-[2-[(p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy]ethyl]-1-methyl-, (+)-, fumarate (1:1) (8CI); (+)-2-[2-[(p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine fumarate
  • Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-,fumarate (1:1)
  • Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-, (2E)-2-butenedioate (1:1)
  • Pyrrolidine, 2-[2-[(p-chloro-.alpha.-methyl-.alpha.-phenylbenzyl)oxy]ethyl]-1-methyl-, ()-
  • Pyrrolidine, 2-[2-[(p-chloro-.alpha.-methyl-.alpha.-phenylbenzyl)oxy]ethyl]-1-methyl-, ()-, fumarate (1:1)
  • Pyrrolidine, 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, [R-(R*,R*)]-, (E)-2-butenedioate (1:1)